Previous / EndoTODAY / List / Next


[Albendazole°ú À¯»ç ¾àÁ¦ (mebendazole, flubendazole)]

1. Ã¥¿¡´Â mebendazoleÀ» ¾²¶ó°í µÇ¾î Àִµ¥ ÇöÀå¿¡¼­´Â ¸ðµÎµé albendazoleÀ» ¾²°í ÀÖÀ»±î¿ä?

µÎ ¾àÀº ºñ½ÁÇϸ鼭µµ ´Ù¸¨´Ï´Ù. ¹Ì¹¦ÇÑ Â÷ÀÌ°¡ ÀÖ½À´Ï´Ù. Mebendazole°ú albendazoleÀº ¸ðµÎ benzimidazole À¯µµÃ¼ÀÔ´Ï´Ù. AlbendazoleÀº Èí¼ö°¡ Àß µÇ°í mebendazoleÀº Èí¼ö°¡ ¾È µË´Ï´Ù. ¿ì¸®¿¡°Ô Àͼ÷ÇÏÁö ¾ÊÁö¸¸ flubendazoleÀ̶ó´Â ¾àµµ ÀÖ½À´Ï´Ù. Mebendazoleó·³ Èí¼ö°¡ ¾È µÇ´Â ¾àÀÔ´Ï´Ù.


Albendazole

AlbendazoleÀº ü³»¿¡ Èí¼öµÇ¾î °£¿¡¼­ È°¼ºÇüÀÎ albendazole sulphoxide·Î ¹Ù²ò´Ï´Ù. SulphoxideÇüÀº ÃæüÀÇ Æ÷µµ´ç´ë»ç¿¡ °ü¿©ÇÏ´Â tubulin polymerizationÀ» ¾ïÁ¦ÇÕ´Ï´Ù.

AlbendazoleÀº º¸Åë ½ÄÈÄ¿¡ Åõ¾àÇÕ´Ï´Ù. ±×·¯³ª °íÁö¹æ½Ä°ú ÇÔ²² ¾àÀ» º¹¿ëÇÏ¸é °øº¹½Ã º¹¿ë¿¡ ºñÇÏ¿© albendazole sulphoxideÀÇ Ç÷Áß ³óµµ°¡ 5¹è ³ô¾ÆÁý´Ï´Ù. µû¶ó¼­ Á¶Á÷³» ±â»ýÃæÀÌ targetÀÎ °æ¿ì¿¡´Â °íÁö¹æ½Ä°ú ÇÔ²² º¹¿ëÇÏ´Â °ÍÀÌ ÁÁ½À´Ï´Ù. ¹Ý¸é Àå³» ±â»ýÃæÀÌ targetÀÎ °æ¿ì¿¡´Â Èí¼ö¸¦ ÁÙÀ̱â À§ÇÏ¿© °øº¹½Ã ¾àÀ» º¹¿ëÇÏ´Â °ÍÀÌ ÁÁ´Ù´Â ÀÇ°ßµµ Àִµ¥ ÀÌ´Â ¸íÈ®ÇÏÁö ¾Ê½À´Ï´Ù. È°¼ºÈ­µÇÁö ¾ÊÀº albendazoleÀÌ ¾î´À Á¤µµ È¿°úÀûÀÎÁö ¸íÈ®ÇÏÁö ¾Ê±â ¶§¹®ÀÔ´Ï´Ù.

¼­¾ç ±³°ú¼­¿¡´Â albendazoleÀÌ Àå³»±â»ýÃæÀÇ Ä¡·á·Î¼­ °ÅÀÇ ¾ð±ÞµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù. ÀÌ´Â albendazoleÀÌ Àå³»±â»ýÃæ¾àÀ¸·Î FDA ½ÂÀÎÀ» ¹ÞÁö ¸øÇÏ¿´±â ¶§¹®ÀÔ´Ï´Ù. FDA¿¡¼­ ³ª¿Â albendazole ¼³¸í¼­¸¦ º¸¸é neurocysticercosis¿Í hydatid disease¿¡¼­¸¸ ¾²´Â °ÍÀ¸·Î µÇ¾î ÀÖ½À´Ï´Ù.

¿ì¸®³ª¶ó¿¡´Â albendazoleÀ» ¸¸µå´Â ȸ»ç°¡ ¸Å¿ì ¸¹½À´Ï´Ù. ¹Ý¸é mebendazoleÀ» ¸¸µå´Â ȸ»ç´Â µå¹°°í °Ô´Ù°¡ ¸ðµÎ ¼öÃâ¿ëÀÔ´Ï´Ù. ±Ùó ¾à±¹¿¡´Â albendazole¸¸ ÀÖ°í mebendazoleÀº ¾ø½À´Ï´Ù. FlubendazoleÀº °¡²û ÀÖ½À´Ï´Ù.

¿äÄÁµ¥ ¿ì¸®´Â mebendazoleÀÌ ¾ø¾î¼­ albendazoleÀ» ¾²´Â °ÍÀÔ´Ï´Ù. ¹Ý¸é ¹Ì±¹¿¡¼­´Â albendazoleÀÌ ¼ÒÈ­±â ±â»ýÃæ¾àÁ¦·Î Çã°¡¸¦ ¹ÞÁö ¸øÇÏ¿´±â ¶§¹®¿¡ mebendazoleÀ» ¾²°í ÀÖ½À´Ï´Ù. ¹Ì±¹ ±³°ú¼­ ÀúÀÚµéÀº mebendazoleÀ» ±ÇÇÒ ¼ö ¹Û¿¡ ¾ø¾úÀ» °ÍÀÔ´Ï´Ù. Albendazole°ú mebendazoleÀ» ¸ðµÎ ¾µ ¼ö ÀÖ´Ù¸é ¾î¶² °ÍÀ» °ñ¶ó¾ß ÇÒ±î¿ä? ¾Æ¸¶ µÑ ´Ù º° ¹®Á¦ ¾øÀ» °Í °°½À´Ï´Ù. Àú´Â Àͼ÷ÇÑ albendazoleÀ» ¾²°Ú½À´Ï´Ù.


Yahoo! Answers¿¡ albendazole°ú mebendazoleÀÇ Â÷ÀÌ¿¡ ´ëÇÑ ´äº¯ÀÌ ÀÖ¾î ÀϺθ¦ ¼Ò°³ÇÕ´Ï´Ù.

"Each drug has a similar spectrum of activity with albendazole being preferred for strongyloidiasis and cystic hydatid disease caused by Echinococcus granulosus, and each has low systemic absorption. Taking a fatty meal with albendazole helps with absorption.

The drug mebendazole is metabolized to inactive products by the liver (cimetidine inhibits metabolism, but often this is not actually done), but the drug albendazole is metabolized to the active sulfoxide.

Both are usually safe for short term use, but long term use might cause liver problems, leukopenia, hair loss, headaches and fever (at least with albendazole) . Both induce liver metabolism of drugs."


wiseGEEK¿¡ albendazole°ú mebendazoleÀÇ Â÷ÀÌ¿¡ ´ëÇÑ ´äº¯ÀÌ ÀÖ¾î ÀϺθ¦ ¼Ò°³ÇÕ´Ï´Ù.

"Albendazole and mebendazole are effective in the management of intestinal parasites, but albendazole tends to work better in cases where the organisms have formed cysts in muscles and organs. Patients can also tolerate therapy with albendazole better, which may be a consideration in some cases. The best treatment option for intestinal nematode infections can depend on the specific organisms involved, the patient¡¯s age, and medical history, all of which can influence the choice of medication.

Both of these medications work to kill worms in the body. Albendazole and mebendazole are taken in oral doses of varying amounts, depending on the specifics of the infection. Worms in the gut can be killed through direct contact, while albendazole spreads through the bloodstream via intestinal absorption. When it reaches organisms encysted in organs like the liver or deep in the patient¡¯s muscle tissue, it kills them, stopping the infection in its tracks.

Some patients may be advised to take combination therapy with albendazole and mebendazole, or other mixtures of anti-parasitic agents. This can assure complete coverage for an infection, especially in a case where the patient has been colonized by multiple organisms. Treating just one might mean another is missed. Testing after the drug therapy is finished can determine the effectiveness of the treatment. It may be necessary to repeat the dose or to change medications.

Another difference between albendazole and mebendazole that can be important is the patient¡¯s tolerance for the drugs. Treatment with albendazole appears to be better tolerated, with fewer uncomfortable side effects like nausea and vomiting. If a patient had a bad reaction in the past to mebendazole, the other drug may be preferred to keep the patient more comfortable. Concerns may exist about drug interactions in the case of combination therapy or treatment for a patient already on another medication who cannot stop taking it."


2. Flubendazole

[2013-9-16. ¾Öµ¶ÀÚ Áú¹®] ¾È³çÇϽʴϱî? ¾ó¸¶Àü¿¡ ±â»ýÃæÀÌ ÀÖ´Ù°í(ȸÃæ°°´Ù°í ÀÎÅͳݿ¡¼­ ã¾Æº¸°í ¿Ô½À´Ï´Ù) ã¾Æ¿Â Áß±¹ÀÎÀÌ ÀÖ¾î ¾Ëº¥´ÙÁ¹ 400mgÀ» ¾à±¹¿¡¼­ »ç¸ÔÀ¸¶ó°í Àû¾î ÁÖ¾ú½À´Ï´Ù. ÀÌÈÄ Àç¹Ì³­ ÀÏÀÌ ÀÖ¾ú´Âµ¥ Á©ÄÞÀ̶ó´Â ¾àÀ» µé°í ¿Ô½À´Ï´Ù. Àúµµ Á¦ÀÏ Àͼ÷ÇÑ À̸§ÀÇ È¸Ãæ¾àÀ̶ó ´ç¿¬È÷ ¾Ëº¥´ÙÁ¹ À̶ó »ý°¢Çߴµ¥ Ç÷纥´ÙÁ¹ ÀÌ´õ±º¿ä. ~º¥´ÙÁ¹À̶ó´Â À̸§ÀÌ À¯»çÇÏÁö¸¸ Ȥ½Ã¸ô¶ó¼­ ¾à±¹¿¡ ´Ù½Ã ¿¬¶ôÇØ ¾Ëº¥´ÙÁ¹À» ó¹æ ¹Þ°Ô ÇÏ¿´´Âµ¥¿ä. ÀÌ ¾àµµ ¾Ëº¥´ÙÁ¹°ú °°Àº È¿´ÉÀÌ ÀÖ´Ù°í ÇÒ ¼ö ÀÖÀ»±î¿ä? ÀûÀÀµµ °°Àº°¡¿ä?

[2013-9-16. ÁÖÀÎÀå ´äº¯] ÁÁÀº Áú¹® °¨»çÇÕ´Ï´Ù. µÎ °¡Áö ÀÇ°ßÀ» µå¸³´Ï´Ù.

1) ȸÃæ°°Àº °Í°ú ȸÃæÀº ´Ù¸£´Ù°í »ý°¢ÇÕ´Ï´Ù. ȸÃæÀº Ãæü°¡ ¹ÛÀ¸·Î ³ª¿À´Â °æ¿ì°¡ ¸Å¿ì µå¹°±â ¶§¹®¿¡ Ãæü°¡ Ç×¹®À¸·Î ³ª¿ÔÀ¸¸é Ȥ½Ã tapewormÀº ¾Æ´Ñ°¡ ÀǽÉÇØ¾ß ÇÕ´Ï´Ù. ȯÀÚ ¸»À» ÀüÀûÀ¸·Î ¹Ï±â´Â ¾î·Æ´Ù°í º¾´Ï´Ù. TapewormÀº ³³ÀÛÇÑ °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ¸¸¾à tapewormÀ̶ó¸é praziquantelÀ» ½á¾ß Çϱ⠶§¹®¿¡ È®ÀÎÀÌ ÇÊ¿äÇÕ´Ï´Ù.

2) FlubendazoleÀº ȸÃæ¿¡ Àß µè½À´Ï´Ù. »ó¼¼ÇÑ ³»¿ëÀº Àúµµ Àß ¸ô¶ó¼­ äÁ¾ÀÏÆí ÀÓ»ó±â»ýÃæÇÐ(587ÂÊ)ÀÇ ÇØ´ç ºÎºÐÀ» ¿Å±é´Ï´Ù.

Flubendazole: MebendazoleÀÇ ºÒ¼Ò ġȯ »ó»çü·Î¼­ ºÐ¸» °áÁ¤Ã¼ÀÌ´Ù. Àå°üÀ¸·Î °ÅÀÇ Èí¼öµÇÁö ¾ÊÀ¸¸ç, ÀϺΠÈí¼öµÈ °ÍÀº 104½Ã°£¿¡ Ç÷Àå³óµµ ÃÖ°íÄ¡¿¡ ´ÞÇÑ ÈÄ 10-16½Ã°£¿¡ ¸ðµÎ ¹è¼³µÈ´Ù. ÀÛ¿ë±âÀüÀº ÃæüÀÇ microtubue ±â´É°ú ´Ü¹éÁú ´ë»ç¸¦ ¹æÇØÇÔÀ¸·Î½á »ìÃæÀÛ¿ëÀ» ³ªÅ¸³»´Â °ÍÀÌ´Ù. Åõ¿© ¿ë·®¿¡¼­´Â °ÅÀÇ ºÎÀÛ¿ëÀ̳ª µ¶¼ºÀÌ ¾ø´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. µå¹°°Ô °¡º­¿î µÎÅë, ¾îÁö·¯¿ò, º¹ÅëÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ȸÃæÁõ, ±¸ÃæÁõ, ¿äÃæÁõ¿¡ È¿°úÀûÀ̸ç, ÆíÃæÁõ, Æ÷ÃæÁõ(hydatid disease)°ú °³È¸ÃæÁõ¿¡µµ »ç¿ë °¡´É¼ºÀÌ Á¦½ÃµÈ ¹Ù ÀÖ´Ù. ¾î¸¥°ú ¾î¸°ÀÌ ¸ðµÎ 500mgÀ» 1ȸ º¹¿ëÇÑ´Ù.


[Âü°íÀÚ·á]

1) ¿£µµÅõµ¥ÀÌ ±â»ýÃæÇÐ

[Home]